P53- and mevalonate pathway–driven malignancies require Arf6 for metastasis and drug resistance

Drug resistance, metastasis, and a mesenchymal transcriptional program are central features of aggressive breast tumors. The GTPase Arf6, often overexpressed in tumors, is critical to promote epithelial–mesenchymal transition and invasiveness. The metabolic mevalonate pathway (MVP) is associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Ari, Oikawa, Tsukasa, Hashimoto, Shigeru, Sugino, Hirokazu, Yoshikawa, Ayumu, Otsuka, Yutaro, Handa, Haruka, Onodera, Yasuhito, Nam, Jin-Min, Oneyama, Chitose, Okada, Masato, Fukuda, Mitsunori, Sabe, Hisataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828690/
https://www.ncbi.nlm.nih.gov/pubmed/27044891
http://dx.doi.org/10.1083/jcb.201510002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828690/
https://www.ncbi.nlm.nih.gov/pubmed/27044891
http://dx.doi.org/10.1083/jcb.201510002

Ejemplares similares